EYEN - EYENOVIA, INC.

0.92
-0.010   -1.054%

Share volume: 25,647
Last Updated: 04-08-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.05%

PREVIOUS CLOSE
CHG
CHG%
$0.93
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
20%
Profitability 0%
Dept financing 25%
Liquidity 53%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.18%
1 Month
-40.86%
3 Months
751.85%
6 Months
104.44%
1 Year
49.57%
2 Year
-76.10%
Key data
Stock price
$0.92
P/E Ratio 
0.00
DAY RANGE
$0.91 - $1.04
EPS 
-$0.80
52 WEEK RANGE
$0.03 - $2.92
52 WEEK CHANGE
$69.27
MARKET CAP 
33.093 M
YIELD 
N/A
SHARES OUTSTANDING 
64.059 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
02-03-2025
NEXT EARNINGS DATE
04-15-2025
BETA 
2.23
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$47,164
AVERAGE 30 VOLUME 
$457,642
Company detail
CEO: Michael M. Rowe
Region: US
Website: eyenovia.com
Employees: 40
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Eyenovia, Inc. engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. Its product candidates include MicroLine, MicroPine and MydCombi.

Recent news
loading